Bio-Rad Laboratories Class B
BIO.B
9 hedge funds and large institutions have $9.05M invested in Bio-Rad Laboratories Class B in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
13% more funds holding
Funds holding: 8 → 9 (+1)
10% more capital invested
Capital invested by funds: $8.2M → $9.05M (+$842K)
0% more ownership
Funds ownership: 0.52% → 0.52% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCAG
Rehmann Capital Advisory Group
Lansing,
Michigan
|
+$43.2K |
| 2 |
Renaissance Technologies
New York
|
+$33K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Copperwynd Financial
Scottsdale,
Arizona
|
-$28K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CL
1
CSS LLC
Chicago,
Illinois
| $7.6M | – | – | – |
|
|
CF
2
Copperwynd Financial
Scottsdale,
Arizona
| $612K | -$28K | -85 | -5% |
|
|
3
Renaissance Technologies
New York
| $409K | +$33K | +100 | +9% |
|
4
UBS Group
Zurich,
Switzerland
| $190K | – | – | – |
|
5
Morgan Stanley
New York
| $173K | – | – | – |
|
|
RCAG
6
Rehmann Capital Advisory Group
Lansing,
Michigan
| $43.6K | +$43.2K | +131 | New |
|
7
Wells Fargo
San Francisco,
California
| $19K | – | – | – |
|
8
Bank of America
Charlotte,
North Carolina
| $2K | – | – | – |
|
BIO.B Hedge Fund Activity: Q3 2019 in Review
9 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q3 2019, worth a combined $9.05M — up 10% from $8.2M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BIO.B positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Rehmann Capital Advisory Group, opening a new position worth an estimated $43.2K. The largest seller was Copperwynd Financial, cutting an estimated $28K.
- 9 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q3 2019, up from 8 in Q2 2019.
- Funds reported $9.05M of Bio-Rad Laboratories Class B stock for Q3 2019, up 10% quarter-over-quarter.
- 1 fund opened new Bio-Rad Laboratories Class B positions in Q3 2019 and 0 closed out, a net change of +1 holder.
- The largest Bio-Rad Laboratories Class B buyer in Q3 2019 was Rehmann Capital Advisory Group, an estimated $43.2K added.
- The largest Bio-Rad Laboratories Class B seller in Q3 2019 was Copperwynd Financial, an estimated $28K sold.
Based on aggregated 13F filings for Q3 2019.